Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study
Background: Emerging evidence suggests immune checkpoint inhibitor (ICI) therapies can increase the risk of myocarditis —a life-threatening rare adverse event. High quality population-level evidence on the association remains lacking. We investigated this association in a large national cohort in Ch...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-02-01
|
| Serie: | The Lancet Regional Health. Western Pacific |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2666606524002992 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|